Equities

Amdocs Ltd

Amdocs Ltd

Actions
TechnologyTechnology
  • Price (USD)86.28
  • Today's Change-0.13 / -0.15%
  • Shares traded449.30k
  • 1 Year change-0.42%
  • Beta0.7472
Data delayed at least 15 minutes, as of Sep 18 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform3
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 8 analysts offering 12 month price targets for Amdocs Ltd have a median target of 99.60, with a high estimate of 113.00 and a low estimate of 90.00. The median estimate represents a 15.46% increase from the last price of 86.26.
High31.0%113.00
Med15.5%99.60
Low4.3%90.00

Dividends in USD

In 2023, Amdocs Ltd reported a dividend of 1.66 USD, which represents a 9.93% increase over last year. The 4 analysts covering the company expect dividends of 1.84 USD for the upcoming fiscal year, an increase of 11.02%.
Div growth (TTM)9.93%
More ▼

Earnings history & estimates in USD

On Aug 07, 2024, Amdocs Ltd reported 3rd quarter 2024 earnings of 1.62 per share. This result was in line with the consensus of the 5 analysts following the company and exceeded last year's 3rd quarter results by 3.18%.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+1.04%
Amdocs Ltd reported annual 2023 earnings of 5.91 per share on Nov 07, 2023.
Average growth rate+8.26%
More ▼

Revenue history & estimates in USD

Amdocs Limited had 3rd quarter 2024 revenues of 1.25bn. This missed the 1.25bn consensus estimate of the 5 analysts following the company. This was 5.43% above the prior year's 3rd quarter results.
Average growth rate+0.28%
Amdocs Limited had revenues for the full year 2023 of 4.89bn. This was 6.79% above the prior year's results.
Average growth rate+4.60%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.